Benoit Rousseau (Benoît Rousseau)

Years Active: 2018-2020
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Cindy Neuzillet, Andrea Casadei-Gardini, Bertrand Brieau, Caterina Vivaldi, Giovanni Brandi, David Tougeron, Roberto Filippi, Angélique Vienot, Nicola Silvestris, Anne-Laure Pointet, Sara Lonardi, Benoit Rousseau, Mario Scartozzi, Laetitia Dahan, Giuseppe Aprile, Samuel Le Sourd, Ludovic Evesque, Aurélia Meurisse, Astrid Lièvre, Dewi Vernerey, null null, null null
Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer. International journal of cancer 147 (11) (2020)
Marc Hilmi, Cindy Neuzillet, Julien Calderaro, Fouad Lafdil, Jean-Michel Pawlotsky, Benoit Rousseau
Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directions. Journal for immunotherapy of cancer 7 (1) (2019)
Benoit Rousseau, Aude Guillemin, Christophe Duvoux, Cindy Neuzillet, Camille Tlemsani, Philippe Compagnon, Daniel Azoulay, Chaddy Salloum, Alexis Laurent, Alexandre de la Taille, Laurent Salomon, Irène Cholley, Corinne Haioun, Jehan Dupuis, Pierre Wolkenstein, Marie-Bénédicte Matignon, Philippe Grimbert, Christophe Tournigand
Optimal oncologic management and mTOR inhibitor introduction are safe and improve survival in kidney and liver allograft recipients with de novo carcinoma. International journal of cancer 144 (4) (2018)

Benoit Rousseau.css-eqlu8i{font-size:small;padding-left:4px;} (Benoît Rousseau)